InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001773751-24-000125 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-05-03 2024-05-01 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $12.54 -188.9K 0 -100% -$2.37M
D 2024-05-03 2024-05-01 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $2.43 +188.9K 188.9K New +$459.0K
DI 2024-05-03 2024-05-01 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $12.69 -144.4K 1.31M -10% -$1.83M
D 2024-05-03 2024-05-01 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $0.00 -188.9K 1.34M -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-05-01 S D 94,444 $12.54 94,444 D — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.30- $13.015. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Class A Common Stock 2024-05-01 M A 188,888 $2.43 188,888 D Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 — —
3 Common Class A Common Stock 2024-05-01 S D 144,444 $12.69 1,310,422 I — — (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.32- $13.16. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4 Common Class A Common Stock 2024-05-01 S D 94,444 $12.53 0 D — — (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.29- $13.015. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (right to buy) 2024-05-01 M D 188,888 $0.00 1,337,344 D $2.43 · — to 2030-06-17 188,888 Class A Common Stock (F5) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.